A groundbreaking family-based genetic study has uncovered rare variants that appear to be the protective mechanisms behind sustained health in exceptionally long-lived populations. Researchers analyzing families with multiple centenarians and near-centenarians identified one standout mutation capable of suppressing chronic inflammation—a primary driver of age-related disease.
Inflammation, known as inflammaging when chronic, accelerates the onset of cardiovascular disease, cognitive decline, and other age-related conditions. The newly identified genetic variant appears to keep inflammatory markers significantly lower throughout life, effectively extending not just lifespan but healthspan—the years lived in good health.
These findings suggest that targeted interventions mimicking these protective pathways could eventually help broader populations maintain health into advanced age. While the research remains observational and requires validation through larger studies and functional analysis, it points toward a promising direction for geroprotective therapy development.
Read the full article on GMJ Newsroom.
Was this article helpful?
